Panel discussion on large cell lymphomas: subtypes, patient selection and mutations
Andrew Zelenetz et al.
Relapse in DLBCL - addressing the unmet need with brentuximab vedotin
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
Summary of CLL trials presented at ASH 2016
Overview of the T-SPOT assay for diagnosing tuberculosis and cytomegalovirus